All News
Today is September 26, 2024. All times in Eastern Daylight Time.
Positive Phase III Results for Genentech’s Gazyva Show Superiority to Standard Therapy Alone in People With Lupus Nephritis
09/26/2024 - 01:00 AM
BUSINESS WIRE
Canva的應用程式使用者突破10億,積極擴大Developer平台
09/26/2024 - 12:53 AM
BUSINESS WIRE
キャンバ、アプリの利用回数が10億回を突破しことを受け、開発者向けプラットフォームを拡張
09/26/2024 - 12:53 AM
BUSINESS WIRE
应用程序使用量突破10亿促使Canva扩展开发者平台
09/26/2024 - 12:53 AM
BUSINESS WIRE
Canva expande plataforma de desenvolvedores à medida que os usos de aplicativos ultrapassam 1 bilhão
09/26/2024 - 12:52 AM
BUSINESS WIRE
Samenvatting: Canva breidt ontwikkelaarsplatform uit nu app meer dan 1 miljard keer wordt gebruikt
09/26/2024 - 12:52 AM
BUSINESS WIRE
Riassunto: Canva espande la piattaforma per gli sviluppatori mentre l’app supera il miliardo di utilizzi
09/26/2024 - 12:52 AM
BUSINESS WIRE
Faraday Future Announces Senior Leadership Changes to Drive Implementation of Its Dual-Brand Strategy
09/26/2024 - 12:34 AM
BUSINESS WIRE
Tamron Announces 90mm F2.8 Di III VXD Macro Lens for Sony E-mount and Nikon Z-mount cameras; Learn More Info at B&H
09/26/2024 - 12:01 AM
BUSINESS WIRE
AVerMedia Expands Its “GO Series” with the Launch of VERSATI go Microphone and FLEXI go Mic Arm
09/26/2024 - 12:00 AM
BUSINESS WIRE
Hello, Rainy Day Blues: Lee® and STUTTERHEIM Launch New Collaboration
09/26/2024 - 12:00 AM
BUSINESS WIRE
Samenvatting: Nieuwe gegevens tonen aan dat EBGLYSS® (lebrikizumab) van Almirall tot drie jaar lang standvastige controle van de ziekte opleverde bij meer dan 80% van de volwassenen en adolescenten met matige tot ernstige atopische dermatitis
09/25/2024 - 10:11 PM
BUSINESS WIRE
Riassunto: Nuovi dati dimostrano che EBGLYSS® (Lebrikizumab) di Almirall assicura un controllo duraturo della malattia fino a tre anni in oltre l'80% degli adulti e degli adolescenti con dermatite atopica da moderata a grave
09/25/2024 - 10:11 PM
BUSINESS WIRE
De nouvelles données montrent qu'EBGLYSS® (Lebrikizumab) d'Almirall a contrôlé la maladie pendant trois ans chez plus de 80 % des adultes et des adolescents atteints de dermatite atopique modérée à sévère
09/25/2024 - 10:11 PM
BUSINESS WIRE
Resumen: Nuevos datos demuestran que EBGLYSS® (lebrikizumab) de Almirall brindó un control de la enfermedad sostenido durante un máximo de tres años en más del 80 % de los adultos y adolescentes con dermatitis atópica moderada o grave
09/25/2024 - 10:11 PM
BUSINESS WIRE
Neuen Daten zufolge bewirkt EBGLYSS® (Lebrikizumab) von Almirall eine nachhaltige Linderung bei mehr als 80 % der Erwachsenen und Jugendlichen mit mittelschwerer bis schwerer atopischer Dermatitis nach einer Behandlung von bis zu 3 Jahren
09/25/2024 - 10:10 PM
BUSINESS WIRE
易受攻击的API和机器人攻击每年给企业造成高达1860亿美元的损失
09/25/2024 - 10:00 PM
BUSINESS WIRE
TDWP Announces Deal with Summit Next Gen and Provides a Strategic Update
09/25/2024 - 09:58 PM
BUSINESS WIRE
Top Rental Management Software (2024): TurboTenant Property Management Software Reviewed by Compare Before Buying
09/25/2024 - 09:56 PM
BUSINESS WIRE
Best Property Management Software (2024): Top Rental Management Software Ranked by Compare Before Buying
09/25/2024 - 09:38 PM
BUSINESS WIRE
Australia’s Leading Telehealth Platform, Dial A Vet, Offers 24/7 Access to Veterinarians for 7 Million Households
09/25/2024 - 09:25 PM
BUSINESS WIRE
Guardian Pharmacy Services, Inc. Announces Pricing of Upsized Initial Public Offering
09/25/2024 - 09:10 PM
BUSINESS WIRE
AMENDMENT: Anticipated Cash NOI** Range for Fiscal Year 2024 Should Have Been Stated as $273 Million to $278 Million; Primaris REIT Announces Acquisition of Market Leading Regional Shopping Centre, Les Galeries de la Capitale
09/25/2024 - 09:09 PM
BUSINESS WIRE
FICO Survey: Rising Acceptance of 'Liar Loans' Among Malaysian Consumers
09/25/2024 - 09:00 PM
BUSINESS WIRE
FICO Survey: Rising Acceptance of ‘Liar Loans’ Among Filipino Consumers
09/25/2024 - 09:00 PM
BUSINESS WIRE
1
2
3
4
5
6
7
8
9
10
11
...
619
Next »
Site Navigation
Home
Home
Submit a Press Release
Services
News
All News
News with Multimedia
News by Industry
News by Subject
News by Language
Tradeshows & Events
Education
Overview
Blog
Distribution & Media
Media & Journalist Tools
Sample Press Release
Find Your News Online
Disclosure Resources
About Us
Overview
Become a Member
Contact Us
Careers
Business Wire Newsroom
Business Wire Events
Search
Advanced News Search
Advanced News Search
Log In
Sign Up